Dienemann H, Wood J M, Kraetz J, Stalder R, Hofbauer K G
Adv Exp Med Biol. 1983;156:651-60.
The intravenous infusion of bradykinin (20 micrograms/kg X min) induced an initial fall in blood pressure and total peripheral resistance in anaesthetized rats. These changes were accompanied with an increase in cardiac output and stroke volume. These effects were transient and after 20 min of infusion blood pressure and total peripheral resistance were much less decreased than initially. Cardiac output and stroke volume had completely normalized. Lower doses of bradykinin (1 microgram/kg X min), which did not affect blood pressure, induced a reduction in mesenteric and renal vascular resistance. After higher doses (4 or 20 micrograms/kg X min) mesenteric vascular resistance was further decreased but renal vascular resistance was unchanged or markedly increased. This renal vasoconstrictor response was almost absent in rats which were pretreated with indomethacin (4 mg/kg i.v.). Hence the increase in renal vascular resistance was most probably due to the stimulation of the synthesis of prostaglandins, which act as renal vasoconstrictors in the rat.
静脉输注缓激肽(20微克/千克×分钟)可使麻醉大鼠的血压和总外周阻力起初下降。这些变化伴随着心输出量和每搏输出量的增加。这些效应是短暂的,输注20分钟后,血压和总外周阻力的下降幅度远小于起初。心输出量和每搏输出量已完全恢复正常。较低剂量的缓激肽(1微克/千克×分钟)不影响血压,但可使肠系膜和肾血管阻力降低。较高剂量(4或20微克/千克×分钟)后,肠系膜血管阻力进一步降低,但肾血管阻力未变或显著增加。在用吲哚美辛(4毫克/千克静脉注射)预处理的大鼠中,这种肾血管收缩反应几乎不存在。因此,肾血管阻力的增加很可能是由于前列腺素合成受到刺激,而前列腺素在大鼠中起肾血管收缩剂的作用。